Schizophrenia News and Research

Latest Schizophrenia News and Research

Computerized cognitive training shows early promise in schizophrenia

Home-based computerized cognitive training has shown promise as a treatment for young people with schizophrenia, results of a randomized trial indicate.

31 Jan 2014

Psychiatrists urged to monitor metabolic changes in psychosis patients

Japanese psychiatrists are largely aware of the metabolic abnormalities that may arise from antipsychotic treatment, but most do not monitor their patients sufficiently, research shows.

30 Jan 2014

Researchers identify new subgroup of patients suffering from schizophrenia with motor disorders

Researchers led by Marta Barrachina, Institute of Neuropathology of the Bellvitge Biomedical Research Institute (IDIBELL) have identified a new subgroup of patients suffering from schizophrenia characterized by motor disorders.

29 Jan 2014

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Omeros Corporation today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients with schizophrenia. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including schizophrenia and Huntington's disease.

29 Jan 2014

Low levels of pro-inflammatory cytokine in brain are important for cognition

Although inflammation is frequently a cause of disease in the body, research from The University of Texas Health Science Center at San Antonio indicates that low levels of a pro-inflammatory cytokine in the brain are important for cognition. Cytokines are proteins produced by the immune system.

28 Jan 2014

Continuity of care protects mental health patients

Research shows that seeing the same psychiatrist over time is associated with reduced mortality in patients using mental health services, particularly those with bipolar disorder, major depressive disorder, or schizophrenia.

28 Jan 2014

Hippocampal activity may reflect ‘core’ schizophrenia traits

Hippocampal function may be a useful biomarker for the response of patients with schizophrenia to medication, research suggests.

28 Jan 2014

Neurologist receives Perl-UNC Neuroscience Prize for remarkable research on persistent brain activity

The UNC School of Medicine has awarded the 14th Perl-UNC Neuroscience Prize to Marcus Raichle, MD, a neurologist from Washington University in St. Louis who has made remarkable research findings about the persistent brain activity of our at-rest minds.

28 Jan 2014

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled "Method and System for Generating a Virtual Progeny Genome," by the United States Patent and Trademark Office.

28 Jan 2014

Psychosis risk factors have limited predictive power

Factors known to be linked to schizophrenia risk have little predictive power at either the individual or population level, report researchers.

24 Jan 2014

Research reveals new information about the genetic complexity underpinning schizophrenia

The Icahn School of Medicine at Mount Sinai today announced the publication of two papers in the journal Nature that reveal new information about the genetic complexity underpinning schizophrenia. These collaborative studies represent the largest exome sequencing efforts to date to elucidate this mental illness, and together found that the disorder is likely caused by far more rare genetic mutations than previously suspected.

23 Jan 2014

Structural biologists advance efforts to develop new drugs targeting NMDA receptors in brain

Structural biologists at Cold Spring Harbor Laboratory (CSHL) and collaborators at Emory University have obtained important scientific results likely to advance efforts to develop new drugs targeting NMDA receptors in the brain.

23 Jan 2014

Blood methylome offers clues to schizophrenia

Researchers show that a methylome-wide association study of the blood can provide a glimpse of past environmental insults that may contribute to the development of schizophrenia.

22 Jan 2014

Schizophrenia cognition tool promising in bipolar disorder patients

The Brief Assessment of Cognition in Schizophrenia may be an appropriate tool for measuring cognition in elderly patients with bipolar disorder, a pilot study suggests.

22 Jan 2014

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system diseases, today announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease. The program is being conducted under a Special Protocol Assessment agreement with the FDA.

22 Jan 2014

People who are less patient tend to move eyes with greater speed, say researchers

Using a simple study of eye movements, Johns Hopkins scientists report evidence that people who are less patient tend to move their eyes with greater speed. The findings, the researchers say, suggest that the weight people give to the passage of time may be a trait consistently used throughout their brains, affecting the speed with which they make movements, as well as the way they make certain decisions.

22 Jan 2014

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

The 2014 LOUIS-JEANTET PRIZE FOR MEDICINE is awarded to the Italian biochemist Elena Conti, Director of the Department of Structural Cell Biology at the Max-Planck Institute of Biochemistry in Munich (Germany) and to Denis Le Bihan, the French medical doctor, physicist and Director of NeuroSpin, an institute at the French Nuclear and Renewable Energy Commission (CEA) at Saclay near Paris.

22 Jan 2014

Experiencing family death in childhood linked with increased risk of psychosis

Experiencing a family death in childhood is associated with a small but significant increase in risk of psychosis, suggests a paper published today on bmj.com.

21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

Psychosis risk following childhood abuse not down to genetics

Familial risk for psychosis does not account for the association between abuse during childhood and the later development of schizophrenia, a study suggests.

20 Jan 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Computerized cognitive training shows early promise in schizophrenia

Psychiatrists urged to monitor metabolic changes in psychosis patients

Researchers identify new subgroup of patients suffering from schizophrenia with motor disorders

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Low levels of pro-inflammatory cytokine in brain are important for cognition

Continuity of care protects mental health patients

Hippocampal activity may reflect ‘core’ schizophrenia traits

Neurologist receives Perl-UNC Neuroscience Prize for remarkable research on persistent brain activity

GenePeeks receives patent for developing innovative algorithms to create hypothetical "digital babies"

Psychosis risk factors have limited predictive power

Research reveals new information about the genetic complexity underpinning schizophrenia

Structural biologists advance efforts to develop new drugs targeting NMDA receptors in brain

Blood methylome offers clues to schizophrenia

Schizophrenia cognition tool promising in bipolar disorder patients

EnVivo Pharmaceuticals starts encenicline Phase 3 study in patients with Alzheimer's disease

People who are less patient tend to move eyes with greater speed, say researchers

Italian biochemist receives Louis-Jeantet Prize for Medicine for the year 2014

Experiencing family death in childhood linked with increased risk of psychosis

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Psychosis risk following childhood abuse not down to genetics

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Schizophrenia News and Research

Latest Schizophrenia News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in